Recent

% | $
Quotes you view appear here for quick access.

Keryx Biopharmaceuticals Inc. Message Board

mgm2020 1347 posts  |  Last Activity: 5 hours ago Member since: Mar 3, 2010
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • And just so no one calls me a seller or a hypocrite, I use the "core ad trade" strategy with my holdings--in ALL of my stocks. I establish a solid core position and then when conditions and market forces allow, I buy some "extra" shares to trade. Over the last couple of days, with the stock dropping down to as low as $28.75 a week ago I have been taking advantage of the swings to generate a few thousand dollars in extra profit, trading a thousand shares here, a thousand shares there etc... Well, today, with the drop(which is WAY overdone. Robert Baird---REALLY?), not only did I rebuy all of the trading shares that I sold in the $31.50 to $32.50 range, but added 2000 more at a price I did not expect to see again. And while Baird made their call AND KEPT THEIR TARGET PRICE AT $35----a few other agencies were RAISING their targets including Credit Suisse and S&P Capital IQ. I can't see this dip lasting more than a few days, as the company DID just come out and increase their guidance for 2016 by 50%!!! And they were already forecasting a 1000% cumulative growth in installations in the next 36 months and 400% growth in GW in 36 months. From 1GW last year to 4 GW in 2017! And 11 GW total by 2017----BEFORE the 50% increase for 2016. This is, and will be a compelling growth story for at least the next 10-15 years, with free cash generation of more than a BILLION DOLLARS A YEAR starting in 2017! If you can get in in the $20's-----DO IT!

    Sentiment: Strong Buy

  • This is a very strange and very welcome occurrence, and possibly the beginning of a prolonged period of short-covering. The stock had been at the lower end of the recent trading range with it sitting at the bottom Bollinger Band, and it has moved right from the bottom up to the top, since the bands are pretty tight right now. That usually signals that a breakout is coming. It certainly would be something if we got an announcement regarding partnership with 9200(sending the stock much higher), or a new CMO hiring(sending the stock much higher since apparently ALL of the bashers on this board seem to think that is SO significant). And, maybe someone has seen the institutional numbers for last quarter and knows that there will be a big positive surprise coming? In any case, it is great to see the stock rallying on strong volume on a weak market day.

    Sentiment: Strong Buy

  • mgm2020 mgm2020 Jul 21, 2015 12:33 PM Flag

    I do not think I am too optimistic---but I AM optimistic. Isn't that what compels anyone to be "long" a stock? The return on investment? The likelihood of success? If you aren't that type of investor, than you either don't belong in the stock market or should just have a portfolio of blue chips and dividend stocks. IDRA has TREMENDOUS potential, and I choose to see the potential as what it may be if it is fully realized. And IDRA is unlike any other biotech I have been in with it's extensive pipeline and dual platforms. And having the Bakers, as well as Milano as CEO is also a tremendous positive.

    Sentiment: Strong Buy

  • Reply to

    Bet you IDRA does what CYTR just did.

    by jk4763 Jul 21, 2015 7:38 AM
    mgm2020 mgm2020 Jul 21, 2015 12:28 PM Flag

    Don't forget that I was in KERX in the $6's and rode that to the approval of Auryxia and got out mostly in the $15-$16 range while also trading for thousands in extra profit. And I have been in SUNE since the $6's and today it DROPPED to $30!!

    Sentiment: Strong Buy

  • Reply to

    Upgraded

    by planetthoughts Jul 21, 2015 8:35 AM
    mgm2020 mgm2020 Jul 21, 2015 12:00 PM Flag

    Credit Suisse upgraded also and raised target from $42 to $45 based on the Vivent deal adding $3 in value to the stock.

    Sentiment: Strong Buy

  • Reply to

    Tell you what MGM.. I will make you the same bet

    by jk4763 Jul 21, 2015 8:16 AM
    mgm2020 mgm2020 Jul 21, 2015 9:03 AM Flag

    I really was doing my best to NOT respond to you---but anyone that has to say "oh yeah---wanna bet?" just like the 5 year olds do on the playground has a LOT of issues(but we already know that about you). Your OCD is obviously taking over again----are you off your medication? I think that people who say that are even worse than the idiots who say "watch and learn" which I used to place at the very bottom of MB statements, and you can disregard just about everything that those people say. But you probably make those kind of bets all day with your other shopping cart wranglers at "work". "OH YEAH? I bet I can get this cart line up to 50 CARTS!" Fruit salad-----IF you really think that the stock price will not be over $4 by the end of the year, then you also have to think that the 8400 results will not be positive---and it that's the case, then you should not be in the stock, would not be a "long", as you have claimed many times, and would prove yourself to be a compete liar, in addition to a nutjob and an idiot. WHEN the 8400 results come in and they are positive, the stock price will be at least the $6 that JP Morgan has targeted, and then will go higher after that. Please get help---you are heading don a slippery slope.

    Sentiment: Strong Buy

  • Other Positive Developments

    In addition to the buyout news, SunEdison raised its 2016 volume guidance and launched the IPO for its emerging market YieldCo. TerraForm had some news of its own, increasing its 2016 dividend guidance.

    Jobin sees the terms of the deal and all of the related news involving the three companies as positive for the industry and the parties involved.

    “In our view, the transaction reaffirms our constructive stance on the residential solar growth opportunity, structurally higher return outlook, monetization opportunities for assets at 7-8% unlevered IRRs including SRECs/renewals, and further validates the attractiveness of the vertically integrated model for companies with scale,” Jobin explained.

    Outlook

    Credit Suisse believes that the Vivint acquisition adds about $3 per share of value to SunEdison’s stock, and the firm raised its target price for SunEdison from $42 to $45. Credit Suisse has Outperform ratings on the stocks of Vivint, SunEdison and TerraForm.

    Sentiment: Strong Buy

  • mgm2020 mgm2020 Jul 20, 2015 9:46 PM Flag

    In my other post I said somewhere between $9 and $12, so just to be a little more positive, I'll push it into double figures and say $10.10. And my "prize"---even if I'm anywhere within a dollar will be an EARLY RETIREMENT!!

    Sentiment: Strong Buy

  • mgm2020 mgm2020 Jul 20, 2015 6:21 PM Flag

    Right. The float before the offering was nearly 26 million. Adding another 4 million shares(plus the over allotment) adds another 16% to the float.

    Sentiment: Strong Buy

  • Reply to

    Debt Galore

    by rr.rr9989 Jul 20, 2015 5:58 PM
    mgm2020 mgm2020 Jul 20, 2015 6:18 PM Flag

    You are absolutely right! The shorts can not possibly keep their positions as the company keeps expanding, and will be generating billions---not millions--in free cash flow within the next 24-36 months. Until then, it's on to becoming the GLOBAL LEADER in green and alternative energy, far outpacing the competition.

    Sentiment: Strong Buy

  • Reply to

    EOY predictions

    by prospern23 Jul 19, 2015 8:01 PM
    mgm2020 mgm2020 Jul 20, 2015 5:52 PM Flag

    Even though I said $15 in '15 coming into this year-that was really just a fun slogan---although I would LOVE to see that price this year. Maybe with a favorable partnership arrangement with 9200?? But my "realistic" EOY price is somewhere between $9 and $12 thanks to excellent 8400 results with Waldenstrom's, and trials underway in Duchenne's, myositis, DLBCL, and melanoma. I think the melanoma trial is going to be a slam-dunk---and adding a TLR agonist, which can greatly enhance the cancer fighting and recognition ability of checkpoint inhibitors in many types of cancers COULD become the standard of care eventually.

    Sentiment: Strong Buy

  • This is an unbelievable run that this company---and the stock---are on. And there is no reason to think that it is likely to stop any time soon. Accretive acquisition after accretive acquisition, expansion into every imaginable area of alternative energy, and officially now a second revenue-producing yieldco only weeks away. WHAT would possess anyone in their right mind to short this stock or maintain a short position with the company not going more, it seems, than just a few days between significant positive announcements? At the rate SUNE is going, raising their guidance by 50% so far for 2016, it is possible that guidance for 2017 could be increased by 100%-----and the stock would be headed for $75 or more by 2017. It is at least a double from here in the next 18 months.

    Sentiment: Strong Buy

  • with fairly long time horizons and holding periods, so while the actual "shares outstanding" numbers will increase, the true shares in play will not. I expect the same type of increase following this secondary as the last one with a good sigh of relief knowing that the company really does have PLENTY of cash to last well into the future now. And even though the outstanding shares are increasing by 16%, the stock is currently 30% off the recent high, so I expect a quick 15% increase from here, and then trending higher into earnings and the news of WHY the company needed the cash NOW.

    Sentiment: Strong Buy

  • mgm2020 mgm2020 Jul 20, 2015 2:09 PM Flag

    Yes---because my reply contains relevant information and valid points, and some on this board are not aware of the "fake"mgm2020. And, by all means, put me on ignore if you have any questions as to my sincerity or integrity.

    Sentiment: Strong Buy

  • mgm2020 mgm2020 Jul 20, 2015 1:53 PM Flag

    That is correct. One half a drug----$18 Billion! But-----48 months ago you could have bought PCYC under $5. And---no second platform that ISIS has already turned an inferior version of into a $7 BILLION market cap company---and IDRA is standing on the precipice waiting to bring their GSO platform to the world---perfected by the scientist that probably has more knowledge and expertise with GSO's than anyone---Sunir Agrawal.

    Sentiment: Strong Buy

  • I posted this reply to a fake mgm2020, but I know a lot of you ignore those. I thought it was a good one so I put it in a separate thread:
    "Gee---I really hate to see you go. Unfortunately you will miss out on all of the gains that are coming in the next couple of months. This is absolutely one stock that IS worth the wait. I'm sure there were many people that said and did the same thing with PCYC while it was languishing in the $4's for a while that probably got out of the market for good after they kept watching what their investment would have become had they NOT been so impatient. PCYC sold for $255/share, and do you know how many drugs they have? ONE. ONE cancer drug and the company was sold for $18 BILLIOIN!! The same thing with ACAD. So many people sold while the stock sat in the $2's ad $3's for a long time. Today--36 months later, the stock is trading over $50. You know how many drugs ACAD has? NONE approved and just ONE still waiting to file an NDA! Too bad you have no patience. Impatience here will cost thousands--tens of thousands---or even more. This is a time to be BUYING---as I am. There is NOTHING to cause this stock to drop for quite a while-----NOTHING. And the prospects this company has to drive the stock higher are more numerous than any other small-cap biotech. But it won't be a "small"-cap for much longer. SEE YA fake MGM2020"

    Sentiment: Strong Buy

  • something BIG for them to need this cash----could be that they realized that they need to DOUBLE the sales force due to demand. Could be expanding into a few other areas of cancer? And the cash on hand places the company in a much stronger position IF there is any kind of offer in the works.

    Sentiment: Strong Buy

  • Reply to

    I know you bozos hate when i keep saying it

    by jk4763 Jul 20, 2015 10:24 AM
    mgm2020 mgm2020 Jul 20, 2015 11:29 AM Flag

    No answer fruit salad? Do you really think that everyone forgets what you post?

    Sentiment: Strong Buy

  • mgm2020 mgm2020 Jul 20, 2015 11:27 AM Flag

    TROV's cash burn is ridiculously small---only about $1.5-$2 million/quarter. IDRA is in a completely different area of biotech and their R&D expenses are much greater. They are BOTH expanding rapidly. I added 4000 shares to my TROV position so far----but IDRA is by far the largest of my holdings with 105,000 shares now-----and stands to grow by the most percentagewise. You must know what you are talking about before you post, otherwise you look like an idiot-----just like you. And you do realize that TROV increased their float by mush more than IDRA percentagewise---don't you?

    Sentiment: Strong Buy

  • Reply to

    I know you bozos hate when i keep saying it

    by jk4763 Jul 20, 2015 10:24 AM
    mgm2020 mgm2020 Jul 20, 2015 10:49 AM Flag

    Gee---I thought you bought back in. At least that's what you announced to everyone 2 weeks ago. What is it? Or are you admitting that everything you say is a lie?

    Sentiment: Strong Buy

KERX
7.50-0.48(-6.02%)Aug 3 4:00 PMEDT